Skip to main content
SpringerLink
Log in

Glipizide-to-glibenclamide switch cost effective in NIDDM

  • Newsletter Article
  • Published:
PharmacoResources

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glipizide-to-glibenclamide switch cost effective in NIDDM. Pharmacoecon. Outcomes News 43, 6 (1995). https://doi.org/10.1007/BF03319539

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03319539

Keywords

Search

Navigation